title: Promising cell-based immunotherapy using gamma delta T cells: together is better.
abstract: Gamma delta T-cell response to cellular stress signals expressed by tumor cells makes them promising candidates for cancer immunotherapy. The proof of concept for clinical scale propagation of polyclonal γδ T-cell lines with efficient in vitro and in vivo response against cancer is an important step in this direction.
authors.affiliation: Bordeaux University, CIRID and CNRS UMR 5164, Bordeaux, France. jdechanet@cirid.org.
authors.forename: Julie
authors.initials: J
authors.lastname: Déchanet-Merville
mesh_terms: D000818:Animals; D003602:Cytotoxicity, Immunologic; D006801:Humans; D008213:Lymphocyte Activation / Q000276:immunology*; D009369:Neoplasms / Q000276:immunology* / Q000378:metabolism*; D009447:Neuroblastoma / Q000276:immunology* / Q000378:metabolism*; D016692:Receptors, Antigen, T-Cell, gamma-delta / Q000378:metabolism*; D037182:T-Cell Antigen Receptor Specificity / Q000276:immunology*; D016176:T-Lymphocyte Subsets / Q000276:immunology* / Q000378:metabolism*
chemical_list: D016692:Receptors, Antigen, T-Cell, gamma-delta